For those closely following the biotech industry, it may come as no surprise to find that a good number of the companies are based in one of two places: the Bay Area or the Boston area.
Andrew and Allison DeAngelis have the bicoastal lists up this week.
The thinking: One Medical wants to treat people when they're young, but also when they age into Medicare at 65.
"If we're going to try to attract you, how about your parents or your grandparents? Or if you have kids, your kids. We're speaking across a common brand, and ultimately across common technology platforms," One Medical CEO Amir Rubin told us.
Psychedelics companies are acting like biotechs. So maybe it shouldn't be a big surprise that some top biotech VCs are getting on board. Yeji Jesse Lee has the story of $1.1 billion psychedelics company GH Research, which has drawn backing from top healthcare investors.
